0001997038-23-000001.txt : 20231012 0001997038-23-000001.hdr.sgml : 20231012 20231012170313 ACCESSION NUMBER: 0001997038-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231012 DATE AS OF CHANGE: 20231012 EFFECTIVENESS DATE: 20231012 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Iambic Therapeutics, Inc. CENTRAL INDEX KEY: 0001997038 IRS NUMBER: 843364168 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-494624 FILM NUMBER: 231323304 BUSINESS ADDRESS: STREET 1: 5627 OBERLIN DRIVE, SUITE 120 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (626) 592-2520 MAIL ADDRESS: STREET 1: 5627 OBERLIN DRIVE, SUITE 120 CITY: SAN DIEGO STATE: CA ZIP: 92121 D 1 primary_doc.xml X0708 D LIVE 0001997038 Iambic Therapeutics, Inc. 5627 OBERLIN DRIVE, SUITE 120 SAN DIEGO CA CALIFORNIA 92121 (626) 592-2520 DELAWARE Entos, Inc. None Corporation true 2019 Thomas Miller c/o Iambic Therapeutics, Inc. 5627 Oberlin Drive, Suite 120 San Diego CA CALIFORNIA 92121 Executive Officer Director Fred Manby c/o Iambic Therapeutics, Inc. 5627 Oberlin Drive, Suite 120 San Diego CA CALIFORNIA 92121 Executive Officer Director Chao Zhang c/o Iambic Therapeutics, Inc. 5627 Oberlin Drive, Suite 120 San Diego CA CALIFORNIA 92121 Executive Officer Tabbert Teng c/o Iambic Therapeutics, Inc. 5627 Oberlin Drive, Suite 120 San Diego CA CALIFORNIA 92121 Executive Officer Evan Rachlin c/o Iambic Therapeutics, Inc. 5627 Oberlin Drive, Suite 120 San Diego CA CALIFORNIA 92121 Director Kurt von Emster c/o Iambic Therapeutics, Inc. 5627 Oberlin Drive, Suite 120 San Diego CA CALIFORNIA 92121 Director R. Jacob Vogelstein c/o Iambic Therapeutics, Inc. 5627 Oberlin Drive, Suite 120 San Diego CA CALIFORNIA 92121 Director Jishnu Bhattacharjee c/o Iambic Therapeutics, Inc. 5627 Oberlin Drive, Suite 120 San Diego CA CALIFORNIA 92121 Director William Rastetter c/o Iambic Therapeutics, Inc. 5627 Oberlin Drive, Suite 120 San Diego CA CALIFORNIA 92121 Director Biotechnology Decline to Disclose 06b false 2023-09-29 false true false 0 109999999 103230763 6769236 false 18 0 0 0 false Iambic Therapeutics, Inc. /s/ Thomas Miller Thomas Miller Chief Executive Officer 2023-10-12